Aurobindo Pharma informs about analyst meet

28 May 2018 Evaluate

Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed that an analyst / investor call on the Audited Financial Results of the Company for the Year ended 31st March, 2018 is scheduled on 29th May, 2018 at 8:30 AM.

The above information is a part of company’s filings submitted to BSE.


Aurobindo Pharma Share Price

1225.80 0.50 (0.04%)
23-May-2024 15:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1494.95
Dr. Reddys Lab 5882.45
Cipla 1487.45
Zydus Lifesciences 1087.65
Lupin 1631.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.